Title |
The Legal Implications of Detecting Alzheimer’s Disease Earlier
|
---|---|
Published in |
The AMA Journal of Ethic, December 2016
|
DOI | 10.1001/journalofethics.2016.18.12.hlaw1-1612 |
Pubmed ID | |
Authors |
Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, Francis X Shen |
Abstract |
Early detection of Alzheimer's disease (AD) raises a number of challenging legal questions. In this essay, we explore some of those questions, such as: Is a neurological indicator of increased risk for AD a legally relevant brain state before there are any outward behavioral manifestations? How should courts address evidentiary challenges to the admissibility of AD-related neuroimaging? How should the government regulate the marketing of neuroimaging diagnostic tools? How should insurance coverage for the use of these new tools be optimized? We suggest that many voices and multidisciplinary perspectives are needed to answer these questions and ensure that legal responses are swift, efficient, and equitable. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 5 | 20% |
United States | 3 | 12% |
Germany | 1 | 4% |
Canada | 1 | 4% |
Turkey | 1 | 4% |
Italy | 1 | 4% |
Japan | 1 | 4% |
Unknown | 12 | 48% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 18 | 72% |
Practitioners (doctors, other healthcare professionals) | 4 | 16% |
Scientists | 2 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 25 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 28% |
Other | 4 | 16% |
Student > Master | 4 | 16% |
Student > Ph. D. Student | 2 | 8% |
Lecturer | 1 | 4% |
Other | 2 | 8% |
Unknown | 5 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 24% |
Neuroscience | 4 | 16% |
Psychology | 3 | 12% |
Biochemistry, Genetics and Molecular Biology | 2 | 8% |
Social Sciences | 1 | 4% |
Other | 1 | 4% |
Unknown | 8 | 32% |